NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Raymond James Downgrades Vertical Aerospace to Underperform – Funding Worries Grow

Raymond James downgrades Vertical Aerospace to Underperform due to cash runway concerns through mid-June and rising competition for talent from Archer's new Bristol hub.

Raymond James Downgrades Vertical Aerospace to Underperform – Funding Worries Grow
Credit: Vertical Aerospace
Already have an account? Sign in.
02/23/2026 · 8:01 AM
EVTL
/ Don’t stop at just one post.

Related↓

William Blair Starts Coverage on Vertical Aerospace With Bullish View
01/07/2026 · 11:32 AM

William Blair Starts Coverage on Vertical Aerospace With Bullish View

William Blair begins coverage of Vertical Aerospace with an Outperform rating, highlighting its strong position in the growing urban air mobility market.

/ Subscriber only
/ Read more

Feed↓

AstraZeneca Makes $10 Billion Offer to Acquire Obesity Drugmaker Rhythm Pharmaceuticals
Featured/ 11/04/2026 · 5:32 PM

AstraZeneca Makes $10 Billion Offer to Acquire Obesity Drugmaker Rhythm Pharmaceuticals

The non-binding bid values the rare obesity drugmaker at up to $134 a share.

/ Subscriber only
Arm Shares Fall After Modest Third-Quarter Guidance Despite Strong Q2 Results
Featured/ 11/04/2026 · 5:00 PM

Arm Shares Fall After Modest Third-Quarter Guidance Despite Strong Q2 Results

Arm reported record Q2 revenue of $1.44 billion, up 27% year over year, driven by strong licensing growth and rising AI-related demand.

/ Subscriber only
AppLovin Shares Jump After Delivering Record Quarter and Bullish Outlook
11/04/2026 · 4:45 PM

AppLovin Shares Jump After Delivering Record Quarter and Bullish Outlook

Record third-quarter results show AppLovin revenue up 55% to $2.18B and net income up 72% to $1.44B, alongside raised fourth-quarter guidance.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI